Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge

Retrovirology

Volumn 7, Issue , 2010, Pages

  Kumar, Surender B ^a   Leavell, Sarah ^a   Porter, Kyle ^a   Assogba, Barnabe D ^a   Burkhard, Mary J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

L SELECTIN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX MUCOSA; VAGINA MUCOSA; VIRUS TRANSMISSION; ANIMAL; CD4+ T LYMPHOCYTE; CHEMISTRY; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNOLOGY; MUCOSAL IMMUNITY; UTERINE CERVIX; VAGINA; VIROLOGY;

ANIMALS; ANTIGENS, CD4; CATS; CD4-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; DISEASE SUSCEPTIBILITY; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; IMMUNITY, MUCOSAL; IMMUNODEFICIENCY VIRUS, FELINE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPH NODES; MALE; VAGINA;

EID: 77952704904     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-49     Document Type: Article

References (92)

1. Shearer GM, Clerici M, Dalgleish A. Alloimmunization as an AIDS vaccine?. Science 1993, 262:161-162. 10.1126/science.8211133, 8211133.
2. Arthur LO, Bess JW, Urban RG, Strominger JL, Morton WR, Mann DL, Henderson LE, Benveniste RE. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J Virol 1995, 69:3117-3124. 189013, 7707540.
3. Stott EJ, Chan WL, Mills KH, Page M, Taffs F, Cranage M, Greenaway P, Kitchin P. Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine. Lancet 1990, 336:1538-1541. 10.1016/0140-6736(90)93310-L, 1979369.
4. Langlois AJ, Weinhold KJ, Matthews TJ, Greenberg ML, Bolognesi DP. Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res Hum Retroviruses 1992, 8:1641-1652. 10.1089/aid.1992.8.1641, 1457210.
5. Chan WL, Rodgers A, Hancock RD, Taffs F, Kitchin P, Farrar G, Liew FY. Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J Exp Med 1992, 176:1203-1207. 10.1084/jem.176.4.1203, 2119400, 1402662.
6. Karlas JA, Siebelink KH, vPeer MA, Huisman W, Rimmelzwaan GF, Osterhaus AD. Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells. Vet Immunol Immunopathol 1998, 65:353-365. 10.1016/S0165-2427(98)00166-4, 9839884.
7. Karlas JA, Siebelink KH, Peer MA, Huisman W, Cuisinier AM, Rimmelzwaan GF, Osterhaus AD. Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection. J Gen Virol 1999, 80(Pt 3):761-765.
8. Giannecchini S, Isola P, Sichi O, Matteucci D, Pistello M, Zaccaro L, Del Mauro D, Bendinelli M. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts. J Virol 2002, 76:6882-6892. 10.1128/JVI.76.14.6882-6892.2002, 136316, 12072489.
9. Chan WL, Rodgers A, Grief C, Almond N, Ellis S, Flanagan B, Silvera P, Bootman J, Stott J, Kent K, Bomford R. Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac-32H. Aids 1995, 9:223-228.
10. Stott EJ. Anti-cell antibody in macaques. Nature 1991, 353:393. 10.1038/353393a0, 1815549.
11. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, MacDonald KS, Ngugi EN, Plummer FA. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996, 348:1347-1351. 10.1016/S0140-6736(95)12269-2, 8918278.
12. Shearer GM, Pinto LA, Clerici M. Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS. Immunol Today 1999, 20:66-71. 10.1016/S0167-5699(98)01392-9, 10098324.
13. Lehner T, Shearer GM, Hackett CJ, Schultz A, Sharma OK. Alloimmunization as a strategy for vaccine design against HIV/AIDS. AIDS Res Hum Retroviruses 2000, 16:309-313. 10.1089/088922200309188, 10716368.
14. Spruth M, Stoiber H, Kacani L, Schonitzer D, Dierich MP. Neutralization of HIV type 1 by alloimmune sera derived from polytransfused patients. AIDS Res Hum Retroviruses 1999, 15:533-543. 10.1089/088922299311051, 10221530.
15. Pinto LA, Sharpe S, Cohen DI, Shearer GM. Alloantigen-stimulated anti-HIV activity. Blood 1998, 92:3346-3354.
16. Wang Y, Tao L, Mitchell E, Bravery C, Berlingieri P, Armstrong P, Vaughan R, Underwood J, Lehner T. Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Nat Med 1999, 5:1004-1009. 10.1038/10577, 10470076.
17. Sriwanthana B, Hodge T, Mastro TD, Dezzutti CS, Bond K, Stephens HA, Kostrikis LG, Limpakarnjanarat K, Young NL, Qari SH, Lal RB, Chandanayingyong D, McNicholl JM. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand. AIDS Res Hum Retroviruses 2001, 17:719-734. 10.1089/088922201750236997, 11429112.
18. Plummer FA, Ball TB, Kimani J, Fowke KR. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop?. Immunol Lett 1999, 66:27-34. 10.1016/S0165-2478(98)00182-5, 10203031.
19. MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJ, Ball TB, Oyugi J, Njagi E, Gaur LK, Brunham RC, Wade J, Luscher MA, Krausa P, Rowland-Jones S, Ngugi E, Bwayo JJ, Plummer FA. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000, 181:1581-1589. 10.1086/315472, 10823757.
20. MacDonald KS, Embree J, Njenga S, Nagelkerke NJ, Ngatia I, Mohammed Z, Barber BH, Ndinya-Achola J, Bwayo J, Plummer FA. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998, 177:551-556. 10.1086/514243, 9498431.
21. Quayle AJ, Fidel P, Rosenberg ES. Sex, alloimmunisation, and susceptibility to HIV infection. Lancet 2004, 363:503-504. 10.1016/S0140-6736(04)15575-X, 14975608.
22. Krieger J, Coombs R, Collier A, Ross S, Chaloupka K, Cummings D, Murphy V, Corey L. Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. Infect Dis J 1991, 163:386-388.
23. Plummer F, Simonsen J, Cameron D, Ndinya-Achola J, Kreiss J, Gakinya M, Waiyaki P, Cheang M, Piot P, Ronald A. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991, 163:233-239.
24. Spinillo A, Zara F, De Santolo A, Brerra R, Maserati R, Romero E, Filice G. Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected women. Clin Microbiol Infect 1999, 5:605-611. 10.1111/j.1469-0691.1999.tb00416.x, 11851690.
25. WHO/UNAIDS AIDS Epidemic Update. Joint United Nations Programme on HIV/AIDS 2008 2008, WHO/UNAIDS.
26. Quayle AJ, Xu C, Mayer KH, Anderson DJ. T Lymphocytes and Macrophages, but Not Motile Spermatozoa, Are a Significant Source of Human Immunodeficiency Virus in Semen. The Journal of Infectious Diseases 1997, 176:960-968. 10.1086/516541, 9333154.
27. Jeng C, English R, Childers T, Tompkins M, Tompkins W. Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus. J Virol 1996, 70:2474-2480. 190091, 8642675.
28. Assogba BD, Leavell S, Porter K, Burkhard MJ. Mucosal administration of low-dose cell-associated feline immunodeficiency virus promotes viral latency. J Infect Dis 2007, 195:1184-1188. 10.1086/512861, 17357056.
29. Burkhard MJ, Valenski L, Leavell S, Dean GA, Tompkins WA. Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats. Vaccine 2002, 21:258-268. 10.1016/S0264-410X(02)00455-3, 12450701.
30. Howard KE, Fisher IL, Dean GA, Jo Burkhard M. Methodology for isolation and phenotypic characterization of feline small intestinal leukocytes. J Immunol Methods 2005, 302:36-53. 10.1016/j.jim.2005.04.019, 16023664.
31. Stevens R, Howard KE, Nordone S, Burkhard M, Dean GA. Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus. J Virol 2004, 78:8210-8218. 10.1128/JVI.78.15.8210-8218.2004, 15254192.
32. Stevens R, Howard K, Nordone S, Burkhard M, Dean G. Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus. J Virol 2004, 78:8210-8218. 10.1128/JVI.78.15.8210-8218.2004, 446143, 15254192.
33. Howard K, Reckling S, Egan E, Dean G. Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats. Retrovirology 2010, 7:2. 10.1186/1742-4690-7-2, 20085648.
34. Burkhard MJ, Obert LA, O'Neil LL, Diehl LJ, Hoover EA. Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus. AIDS Res Hum Retroviruses 1997, 13:347-355. 10.1089/aid.1997.13.347, 9071435.
35. Reid G, Rigby M, McDonald M, Hosie M, Neil J, Jarrett O. Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24. Aids 1991, 5:1477-1483. 10.1097/00002030-199112000-00010, 1667575.
36. Catalina MD, Carroll MC, Arizpe H, Takashima A, Estess P, Siegelman MH. The route of antigen entry determines the requirement for L-selectin during immune responses. J Exp Med 1996, 184:2341-2351. 10.1084/jem.184.6.2341, 2196391, 8976188.
37. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996, 272:60-66. 10.1126/science.272.5258.60, 8600538.
38. Hengel RL, Thaker V, Pavlick MV, Metcalf JA, Dennis G, Yang J, Lempicki RA, Sereti I, Lane HC. Cutting Edge: L-Selectin (CD62L) Expression Distinguishes Small Resting Memory CD4+ T Cells That Preferentially Respond to Recall Antigen. J Immunol 2003, 170:28-32.
39. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712. 10.1038/44385, 10537110.
40. Gebhard DH, Dow JL, Childers TA, Alvelo JI, Tompkins MB, Tompkins WA. Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J Infect Dis 1999, 180:1503-1513. 10.1086/315089, 10515809.
41. Lankford S, Petty C, LaVoy A, Reckling S, Tompkins W, Dean GA. Cloning of feline FOXP3 and detection of expression in CD4+CD25+ regulatory T cells. Veterinary immunology and immunopathology 2008, 122:159-166. 10.1016/j.vetimm.2007.11.007, 2277518, 18180044.
42. Willer DO, Guan Y, Luscher MA, Li B, Pilon R, Fournier J, Parenteau M, Wainberg MA, Sandstrom P, MacDonald KS. Multi-Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge of Cynomolgus Macaques Immunized with "Hyperattenuated" SIV Constructs. J Virol 2010, 84:2304-2317. 10.1128/JVI.01995-09, 20032177.
43. Bolton DL, Minang JT, Trivett MT, Song K, Tuscher JJ, Li Y, Piatak M, O'Connor D, Lifson JD, Roederer M, Ohlen C. Trafficking, Persistence, and Activation State of Adoptively Transferred Allogeneic and Autologous Simian Immunodeficiency Virus-Specific CD8+ T Cell Clones during Acute and Chronic Infection of Rhesus Macaques. J Immunol 2010, 184:303-314. 10.4049/jimmunol.0902413, 19949089.
44. Vagenas P, Williams VG, Piatak MJ, Bess JWJ, Lifson JD, Blanchard JL, Gettie A, Robbiani M. Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239. JAIDS Journal of Acquired Immune Deficiency Syndromes 2009, 52:433-442.
45. Tompkins MB, Tompkins WA. Lentivirus-induced immune dysregulation. Vet Immunol Immunopathol 2008, 123:45-55. 10.1016/j.vetimm.2008.01.011, 2410212, 18289702.
46. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, Hamann D, Prins M, Miedema F. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. Aids 2003, 17:1881-1888. 10.1097/00002030-200309050-00006, 12960820.
47. Davidson M, Rottman J, English R, Lappin M, Tompkins M. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am J Pathol 1993, 143:1486-1497. 1887187, 8238262.
48. Dean GA, Bernales JA, Pedersen NC. Effect of feline immunodeficiency virus on cytokine response to Listeria monocytogenes in vivo. Veterinary immunology and immunopathology 1998, 65:125-138. 10.1016/S0165-2427(98)00148-2, 9839868.
49. Thibault S, Tardif MR, Gilbert C, Tremblay MJ. Virus-associated host CD62L increases attachment of human immunodeficiency virus type 1 to endothelial cells and enhances trans infection of CD4+ T lymphocytes. J Gen Virol 2007, 88:2568-2573. 10.1099/vir.0.83032-0, 17698668.
50. Ding Z, Issekutz TB, Downey GP, Waddell TK. L-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration. Blood 2003, 101:4245-4252. 10.1182/blood-2002-06-1782, 12609846.
51. Howard KE, Burkhard MJ. FIV infection induces unique changes in phenotype and cellularity in the medial iliac lymph node and intestinal IEL. AIDS Res Hum Retroviruses 2007, 23:720-728. 10.1089/aid.2006.0025, 17530999.
52. James SP. Mucosal T-cell function. Gastroenterol Clin North Am 1991, 20:597-612.
53. Vahlenkamp TW, Tompkins MB, Tompkins WA. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells. J Immunol 2004, 172:4752-4761.
54. Mexas AM, Fogle JE, Tompkins WA, Tompkins MB. CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection. Vet Immunol Immunopathol 2008, 126:263-272. 10.1016/j.vetimm.2008.08.003, 2606045, 18799222.
55. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4+CD25+ T Cells Regulate Virus-specific Primary and Memory CD8+ T Cell Responses. The Journal of Experimental Medicine 2003, 198:889-901. 10.1084/jem.20030171, 2194203, 12975455.
56. Baumforth KR, Birgersdotter A, Reynolds GM, Wei W, Kapatai G, Flavell JR, Kalk E, Piper K, Lee S, Machado L, Hadley K, Sundblad A, Sjoberg J, Bjorkholm M, Porwit AA, Yap LF, Teo S, Grundy RG, Young LS, Ernberg I, Woodman CB, Murray PG. Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells. Am J Pathol 2008, 173:195-204. 10.2353/ajpath.2008.070845, 2438297, 18502823.
57. Robertson SJ, Messer RJ, Carmody AB, Hasenkrug KJ. In Vitro Suppression of CD8+ T Cell Function by Friend Virus-Induced Regulatory T Cells. J Immunol 2006, 176:3342-3349.
58. Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C, Blum HE, von Weizsacker F, Thimme R. T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection. J Virol 2005, 79:7860-7867. 10.1128/JVI.79.12.7860-7867.2005, 1143651, 15919940.
59. Eggena MP, Barugahare B, Jones N, Okello M, Mutalya S, Kityo C, Mugyenyi P, Cao H. Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation. J Immunol 2005, 174:4407-4414.
60. Kinter AL, Horak R, Sion M, Riggin L, McNally J, Lin Y, Jackson R, O'shea A, Roby G, Kovacs C, Connors M, Migueles SA, Fauci AS. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. AIDS Res Hum Retroviruses 2007, 23:438-450. 10.1089/aid.2006.0162, 17411377.
61. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005, 6:338-344. 10.1038/ni1180, 15785759.
62. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005, 174:1783-1786.
63. Fogle JE, Mexas AM, Tompkins WA, Tompkins MB. CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism. AIDS Res Hum Retroviruses 2010, 26:201-216. 10.1089/aid.2009.0162, 20156102.
64. Sanchez-Fueyo A, Sandner S, Habicht A, Mariat C, Kenny J, Degauque N, Zheng XX, Strom TB, Turka LA, Sayegh MH. Specificity of CD4+CD25+ regulatory T cell function in alloimmunity. J Immunol 2006, 176:329-334. 2841032, 16365425.
65. Zang W, Lin M, Kalache S, Zhang N, Kruger B, Waaga-Gasser AM, Grimm M, Hancock W, Heeger P, Schroppel B, Murphy B. Inhibition of the Alloimmune Response through the Generation of Regulatory T Cells by a MHC Class II-Derived Peptide. J Immunol 2008, 181:7499-7506.
66. Grene E, Pinto LA, Cohen SS, Mac Trubey C, Trivett MT, Simonis TB, Liewehr DJ, Steinberg SM, Shearer GM. Generation of alloantigen-stimulated anti-human immunodeficiency virus activity is associated with HLA-A 02 expression. J Infect Dis 2001, 183:409-416. 10.1086/318085, 11133372.
67. Habeshaw J, Hounsell E, Dalgleish A. Does the HIV envelope induce a chronic graft-versus-host-like disease?. Immunol Today 1992, 13:207-210. 10.1016/0167-5699(92)90155-Z, 1627248.
68. Whittemore JC, Hawley JR, Jensen WA, Lappin MR. Antibodies against Crandell Rees Feline Kidney (CRFK) Cell Line Antigens, -Enolase, and Annexin A2 in Vaccinated and CRFK Hyperinoculated Cats. Journal of Veterinary Internal Medicine 2010, 24:306-313. 10.1111/j.1939-1676.2010.0476.x, 20136712.
69. Reggeti F, Bienzle D. Alloimmunity does not protect from challenge with the feline immunodeficiency virus. Vet Immunol Immunopathol 2008, 124:152-162. 10.1016/j.vetimm.2008.03.010, 18471896.
70. Davidson JB, Douglas GC. Modulation of integrin function inhibits HIV transmission to epithelial cells and fertilization. J Reprod Immunol 1998, 41:271-290. 10.1016/S0165-0378(98)00064-3, 10213316.
71. Krieger JN, Coombs RW, Collier AC, Ross SO, Chaloupka K, Cummings DK, Murphy VL, Corey L. Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. J Infect Dis 1991, 163:386-388.
72. Tindall B, Evans L, Cunningham P, McQueen P, Hurren L, Vasak E, Mooney J, Cooper DA. Identification of HIV-1 in semen following primary HIV-1 infection. Aids 1992, 6:949-952. 10.1097/00002030-199209000-00006, 1388906.
73. Lewis DE, Yoffe B, Bosworth CG, Hollinger FB, Rich RR. Human immunodeficiency virus-induced pathology favored by cellular transmission and activation. Faseb J 1988, 2:251-255.
74. Yamamoto JK, Hansen H, Ho EW, Morishita TY, Okuda T, Sawa TR, Nakamura RM, Pedersen NC. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc 1989, 194:213-220.
75. Jordan H, Howard J, Sellon R, Wildt D, Tompkins W, Kennedy-Stoskopf S. Transmission of feline immunodeficiency virus in domestic cats via artificial insemination. J Virol 1996, 70:8224-8228. 190907, 8892958.
76. Jordan HL, Howard J, Barr MC, Kennedy-Stoskopf S, Levy JK, Tompkins WA. Short Communication: Feline Immunodeficiency Virus Is Shed in Semen from Experimentally and Naturally Infected Cats. AIDS Research and Human Retroviruses 1998, 14:1087-1092. 10.1089/aid.1998.14.1087, 9718125.
77. Jordan HL, Liang Y, Hudson LC, Tompkins WA. Expression of feline immunodeficiency virus in semen during acute infection. Am J Vet Res 1999, 60:211-215.
78. Bucci JG, English RV, Jordan HL, Childers TA, Tompkins MB, Tompkins WA. Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus. J Infect Dis 1998, 177:18-25. 10.1086/513822, 9419165.
79. Moench TR, Whaley KJ, Mandrell TD, Bishop BD, Witt CJ, Cone RA. The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum. Aids 1993, 7:797-802. 10.1097/00002030-199306000-00006, 8395855.
80. Bishop SA, Stokes CR, Gruffydd-Jones TJ, Whiting CV, Harbour DA. Vaginal and rectal infection of cats with feline immunodeficiency virus. Vet Microbiol 1996, 51:217-227. 10.1016/0378-1135(96)00038-7, 8870185.
81. O'Neil L, Burkhard M, Hoover E. Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol 1996, 70:2894-2901. 190147, 8627764.
82. Obert L, Hoover E. Feline immunodeficiency virus clade C mucosal transmission and disease courses. AIDS Res Hum Retroviruses 2000, 16:677-688. 10.1089/088922200308909, 10791878.
83. Burkhard M, Valenski L, Leavell S, Dean G, Tompkins W. Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats. Vaccine 2002, 21:258-268. 10.1016/S0264-410X(02)00455-3, 12450701.
84. Lewis P, Nduati R, Kreiss Joan K, John Grace C, Richardson Barbra A, Mbori-Ngacha D, Ndinya-Achola J, Overbaugh J. Cell-Free Human Immunodeficiency Virus Type 1 in Breast Milk. The Journal of Infectious Diseases 1998, 177:34-39. 10.1086/513816, 9419167.
85. Kaizu M, Weiler AM, Weisgrau KL, Vielhuber KA, May G, Piaskowski SM, Furlott J, Maness NJ, Friedrich TC, Loffredo JT, Usborne A, Rakasz EG. Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates. J Infect Dis 2006, 194:912-916. 10.1086/507308, 16960778.
86. Howard K, Reckling S, Egan E, Dean G. Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats. Retrovirology 2010, 7:2. 10.1186/1742-4690-7-2, 2835650, 20085648.
87. Mellors JW, Muñoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997, 126:946-954.
88. Rodríguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, Kitahata M, Boswell SL, Mathews WC, Bangsberg DR, Martin J, Whalen CC, Sieg S, Yadavalli S, Deeks SG, Lederman MM. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006, 296:1498-1506. 10.1001/jama.296.12.1498, 17003398.
89. Gibbons J, Cory JM, Hewlett IK, Epstein JS, Eyster ME. Silent infections with human immunodeficiency virus type 1 are highly unlikely in multitransfused seronegative hemophiliacs. Blood 1990, 76:1924-1926.
90. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 1994, 93:1293-1297. 10.1172/JCI117085, 294083, 8132769.
91. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T, Takiguchi M, Schultz T, McMichael A, Whittle H. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995, 1:59-64. 10.1038/nm0195-59, 7584954.
92. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, Shearer GM. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992, 165:1012-1019.